查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1611308

去腎神經技術市場：按技術、按原因 - 2025-2030 年全球預測

Renal Denervation Technologies Market by Technology (Microinfusion, Radiofrequency, Ultrasound), Cause (Diabetes, Heart Failure, Hypertension) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年腎去神經技術市值為3.1144億美元，預計到2024年將達到3.7415億美元，複合年成長率為18.02%，預計到2030年將達到9.9333億美元。

去腎神經技術是一種專注於破壞腎動脈神經活動以治療頑固性高血壓和相關心血管疾病的醫療程序。這種微創手術使用射頻消融術、超音波和其他治療方法來減少交感神經活動，為對傳統治療方法沒有反應的患者提供了另一種選擇。高血壓及其相關風險的盛行率不斷增加，從而推動了對創新治療解決方案的需求，因此需要去腎神經術。腎去神經術的應用範圍已從高血壓擴展到慢性腎臟病、心臟衰竭和METABOLIC INC.症候群，擴大了醫院和專科診所的最終用途範圍。

主要市場統計
基準年[2023] 31144萬美元
預計年份 [2024] 37415萬美元
預測年份 [2030] 99333萬美元
複合年成長率（%） 18.02%

去腎神經技術的市場開拓受到世界人口老化、高血壓發病率上升、設備技術進步以及已開發地區支持性報銷政策等因素的影響。改進的導管和非侵入性技術等創新帶來了巨大的商機。然而，有限的長期療效資料、嚴格的法規環境、高昂的設備成本以及新興市場的認知度低給市場拓展帶來了挑戰。為了抓住機遇，公司應注重策略夥伴關係關係，開拓全面的臨床試驗資料，並在開拓的市場中拓展地域。

創新研究領域包括改進消融技術、尋找個人化治療的遺傳標記以及開發用於患者管理的整合監測設備。去腎神經市場的本質是動態的，其特徵是不斷的技術進步和日益激烈的競爭。公司必須優先考慮設備設計、功效和安全性方面的創新，以提高採用率。此外，針對醫療保健專業人員和患者的教育舉措對於提高對腎去神經術益處的認知至關重要。隨著市場的發展，透過促進該技術在各種醫療應用中的接受度，同時解決成本和可及性等痛點，將具有巨大的成長潛力。

市場動態：快速發展的去腎神經技術市場的關鍵市場洞察

供需的動態交互作用正在改變腎去神經技術市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 人口老化加劇和高血壓盛行率上升
    • 微創手術日益偏好青睞
    • 擴大醫療支出和基礎設施發展
  • 市場限制因素
    • 去腎神經手術缺乏報銷
  • 市場機會
    • 正在進行的腎去神經技術研究
    • 新產品上市並獲得多個監管機構的核准
  • 市場挑戰
    • 缺乏與 RDN 手術相關的長期臨床資料和風險

波特五力：駕馭去腎臟神經科技市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解去腎神經技術市場的外部影響

外部宏觀環境因素在塑造去腎神經技術市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解去腎神經技術市場的競爭格局

對腎去神經技術市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣去腎神經技術市場供應商的績效評估

FPNV 定位矩陣是評估腎去神經技術市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃去腎神經技術市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對腎臟去神經技術市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人口老化加劇和高血壓盛行率上升
      • 人們對微創手術的興趣日益濃厚
      • 擴大醫療保健支出並改善基礎設施
    • 抑制因素
      • 腎去神經手術缺乏報銷
    • 機會
      • 腎去神經技術的持續研究與調查
      • 新產品上市並獲得多個監管機構核准
    • 任務
      • 缺乏與 RDN 手術相關的長期臨床資料和風險
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章去腎臟神經技術市場：依技術分類

  • 微量輸液
  • 無線電頻率
  • 超音波

第7章去腎臟神經技術市場的原因

  • 糖尿病
  • 心臟衰竭
  • 高血壓

第8章 美洲去腎神經技術市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區去腎臟神經技術市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲去腎臟神經技術市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Ablative Solutions, Inc.
  • Boston Scientific Corporation
  • Cordis Corporation
  • Medtronic PLC
  • Mentice
  • Mercator Medsystems, Inc.
  • Otsuka Medical Devices Co., Ltd.
  • Recor Medical, Inc.
  • SoniVie Ltd.
  • Symple Surgical, Inc.
  • Terumo Corporation
Product Code: MRR-02026C4CB064

The Renal Denervation Technologies Market was valued at USD 311.44 million in 2023, expected to reach USD 374.15 million in 2024, and is projected to grow at a CAGR of 18.02%, to USD 993.33 million by 2030.

Renal denervation technologies are medical procedures focused on disrupting nerve activity in the renal arteries to treat resistant hypertension and related cardiovascular conditions. This minimally invasive technique involves using radiofrequency ablation, ultrasound, or other modalities to reduce sympathetic nerve activity, offering an alternative for patients unresponsive to conventional therapies. The necessity of renal denervation arises from the increasing prevalence of hypertension and associated risks, driving demand for innovative treatment solutions. Its applications are extending beyond hypertension to include chronic kidney disease, heart failure, and metabolic syndrome, enhancing the procedure's end-use scope in hospitals and specialty clinics.

KEY MARKET STATISTICS
Base Year [2023] USD 311.44 million
Estimated Year [2024] USD 374.15 million
Forecast Year [2030] USD 993.33 million
CAGR (%) 18.02%

Market growth for renal denervation technologies is influenced by factors like an aging global population, rising rates of hypertension, advances in device technology, and supportive reimbursement policies in developed regions. Innovations, such as improved catheters and non-invasive techniques, present significant opportunities. However, market expansion is challenged by limited long-term efficacy data, stringent regulatory environments, high device costs, and lack of awareness in emerging markets. To seize opportunities, companies should focus on strategic partnerships, developing comprehensive clinical trial data, and expanding geographical footprint in underpenetrated markets.

Innovative research areas include improving ablation techniques, exploring genetic markers for personalized treatment, and developing integrated monitoring devices for patient management. The nature of the renal denervation market is dynamic, characterized by ongoing technological advancements and increasing competition. Companies should prioritize innovation in device design, efficacy, and safety to enhance adoption rates. Furthermore, educational initiatives targeting healthcare professionals and patients are crucial to raising awareness about the benefits of renal denervation. As the market evolves, there is significant potential for growth by addressing pain points such as cost and accessibility while promoting acceptance of the technology across diverse medical applications.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Renal Denervation Technologies Market

The Renal Denervation Technologies Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing aging population and rising prevalence of hypertension
    • Increasing preference for minimally invasive procedures
    • Expanding healthcare spending and infrastructure improvement
  • Market Restraints
    • Lack of reimbursements for renal denervation procedures
  • Market Opportunities
    • Ongoing studies and research about renal denervation technologies
    • New product launches and approvals by several regulatory agencies
  • Market Challenges
    • Lack of long-term clinical data and risks associated with RDN procedure

Porter's Five Forces: A Strategic Tool for Navigating the Renal Denervation Technologies Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Renal Denervation Technologies Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Renal Denervation Technologies Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Renal Denervation Technologies Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Renal Denervation Technologies Market

A detailed market share analysis in the Renal Denervation Technologies Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Renal Denervation Technologies Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Renal Denervation Technologies Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Renal Denervation Technologies Market

A strategic analysis of the Renal Denervation Technologies Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Renal Denervation Technologies Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Ablative Solutions, Inc., Boston Scientific Corporation, Cordis Corporation, Medtronic PLC, Mentice, Mercator Medsystems, Inc., Otsuka Medical Devices Co., Ltd., Recor Medical, Inc., SoniVie Ltd., Symple Surgical, Inc., and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Renal Denervation Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Microinfusion, Radiofrequency, and Ultrasound.
  • Based on Cause, market is studied across Diabetes, Heart Failure, and Hypertension.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing aging population and rising prevalence of hypertension
      • 5.1.1.2. Increasing preference for minimally invasive procedures
      • 5.1.1.3. Expanding healthcare spending and infrastructure improvement
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of reimbursements for renal denervation procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing studies and research about renal denervation technologies
      • 5.1.3.2. New product launches and approvals by several regulatory agencies
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of long-term clinical data and risks associated with RDN procedure
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Renal Denervation Technologies Market, by Technology

  • 6.1. Introduction
  • 6.2. Microinfusion
  • 6.3. Radiofrequency
  • 6.4. Ultrasound

7. Renal Denervation Technologies Market, by Cause

  • 7.1. Introduction
  • 7.2. Diabetes
  • 7.3. Heart Failure
  • 7.4. Hypertension

8. Americas Renal Denervation Technologies Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Renal Denervation Technologies Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Renal Denervation Technologies Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Ablative Solutions, Inc.
  • 3. Boston Scientific Corporation
  • 4. Cordis Corporation
  • 5. Medtronic PLC
  • 6. Mentice
  • 7. Mercator Medsystems, Inc.
  • 8. Otsuka Medical Devices Co., Ltd.
  • 9. Recor Medical, Inc.
  • 10. SoniVie Ltd.
  • 11. Symple Surgical, Inc.
  • 12. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. RENAL DENERVATION TECHNOLOGIES MARKET RESEARCH PROCESS
  • FIGURE 2. RENAL DENERVATION TECHNOLOGIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. RENAL DENERVATION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. RENAL DENERVATION TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. RENAL DENERVATION TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. RENAL DENERVATION TECHNOLOGIES MARKET DYNAMICS
  • TABLE 7. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY MICROINFUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY RADIOFREQUENCY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM RENAL DENERVATION TECHNOLOGIES MARKET SIZE, BY CAUSE, 2018-2030 (USD MILLION)
  • TABLE 101. RENAL DENERVATION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. RENAL DENERVATION TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023